Philippe Cardot
Papers
1
Total Citations
102
H-Index
1
About
Philippe Cardot is a leading figure in bioanalytical chemistry and pharmaceutical analysis, with a primary focus on the development of advanced chromatographic and mass spectrometric methods for therapeutic drug monitoring. His most cited work, a 2000 study on the simultaneous determination of four anthracyclines and their three metabolites in human serum using liquid chromatography–electrospray mass spectrometry, has garnered 102 citations and remains a cornerstone in the field of anticancer drug analysis. This contribution exemplifies his expertise in tackling complex biological matrices, enabling precise quantification of chemotherapeutic agents and their metabolites—a critical step for personalized dosing and toxicity management. Cardot’s research has significantly advanced the understanding of drug metabolism and pharmacokinetics, directly impacting clinical oncology. His methodological innovations, combining high-resolution separation with sensitive detection, have set benchmarks for bioanalytical protocols. Beyond this landmark paper, his work continues to influence the design of robust, high-throughput assays for pharmaceutical development. For students and researchers, Cardot’s career demonstrates how rigorous analytical chemistry can bridge laboratory science and patient care, offering a model for translating complex chemical analyses into tangible clinical benefits.
Research Focus
Key Achievements
Top Papers
- 1